36053951|t|Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral Sclerosis.
36053951|a|OBJECTIVES: Reactivation of HERV-K(HML-2) has been found in subsets of individuals with amyotrophic lateral sclerosis (ALS). This study examines the antibody response against HML-2 in ALS and analyzes its clinical relevance. METHODS: Antibodies to HML-2 envelope (env) were analyzed using a peptide array for epitope mapping and by a peptide enzyme-linked immunosorbent assay (ELISA) in 242 healthy donors, and 243 ALS and 85 multiple sclerosis (MS) individuals. Extracellular levels of HML-2 were analyzed by digital polymerase chain reaction (PCR). RESULTS: Antibodies in the sera of ALS individuals recognized more HML-2 env peptides compared to healthy controls (p < 0.0001). ALS individuals had higher levels of HML-2 than healthy donors (p = 0.02) and higher antibody levels against a select HML-2 env peptide compared to healthy donors or individuals with multiple sclerosis (p < 0.0001). 55.14% of ALS compared to 21.16% of healthy donors and 13.10% of MS individuals had antibodies against the HML-2 peptide (AUC = 0.769, p < 0.0001). Levels of extracellular HML-2 DNA in serum (p = 0.02) and the number of HML-2 env peptides recognized by ALS sera (p = 0.02) correlated with disease duration. Among ALS individuals, lower levels of HML-2 antibodies were associated with a definite diagnosis per EL Escorial criteria (p = 0.03), and with a lower predicted (p = 0.02) and observed survival (p = 0.03). INTERPRETATION: There is a differential antibody response against specific epitopes of HML-2 env in ALS and controls, suggesting epitope spreading, likely due to persistent antigenic exposure following reactivation of the viral genes. Low levels of antibodies to HML-2 env in ALS are associated with poor prognosis and decreased survival probability. ANN NEUROL 2022;92:782-792.
36053951	21	26	HML-2	Gene	10462
36053951	48	77	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
36053951	114	119	HML-2	Gene	10462
36053951	167	196	amyotrophic lateral sclerosis	Disease	MESH:D000690
36053951	198	201	ALS	Disease	MESH:D000690
36053951	254	259	HML-2	Gene	10462
36053951	263	266	ALS	Disease	MESH:D000690
36053951	327	332	HML-2	Gene	10462
36053951	494	497	ALS	Disease	MESH:D000690
36053951	505	523	multiple sclerosis	Disease	MESH:D009103
36053951	525	527	MS	Disease	MESH:D009103
36053951	566	571	HML-2	Gene	10462
36053951	665	668	ALS	Disease	MESH:D000690
36053951	697	702	HML-2	Gene	10462
36053951	759	762	ALS	Disease	MESH:D000690
36053951	796	801	HML-2	Gene	10462
36053951	877	882	HML-2	Gene	10462
36053951	942	960	multiple sclerosis	Disease	MESH:D009103
36053951	985	988	ALS	Disease	MESH:D000690
36053951	1040	1042	MS	Disease	MESH:D009103
36053951	1082	1087	HML-2	Gene	10462
36053951	1147	1152	HML-2	Gene	10462
36053951	1195	1200	HML-2	Gene	10462
36053951	1228	1231	ALS	Disease	MESH:D000690
36053951	1288	1291	ALS	Disease	MESH:D000690
36053951	1321	1326	HML-2	Gene	10462
36053951	1576	1581	HML-2	Gene	10462
36053951	1589	1592	ALS	Disease	MESH:D000690
36053951	1752	1757	HML-2	Gene	10462
36053951	1765	1768	ALS	Disease	MESH:D000690
36053951	Association	MESH:D000690	10462

